Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...
Mirum Pharmaceuticals, Inc. stock surged 150% on rare disease treatments, but faces challenges with profitability and ...
The Breakthrough Therapy designation is supported by positive interim data from the phase 2b VANTAGE study (ClinicalTrials.gov Identifier: NCT05050136) that evaluated the efficacy and safety of ...
Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.
Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report), retaining the price target ...
Pale or clay-colored poop can occur due to an underlying biliary condition, liver disease, gallbladder problems, tumors, or ...
Kayfanda® (odevixibat) approved as new treatment choice for cholestatic pruritus in children from six months with the rare liver condition, Alagille Syndrome E.U. marketing authorization for Kayfanda ...
A drug called ursodeoxycholic acid may help protect the liver. It works by improving bile flow, but it doesn’t treat cholangitis itself. The signs and symptoms of cholangitis will vary from ...
This causes acid reflux: a backflow of stomach acid, bile, and food up into your esophagus ... and non-steroidal anti-inflammatory drugs (NSAIDs). In addition, several conditions can have a lasting ...